SEC 13F Intelligence

Exome Asset Management LLC / TVTX

Exome Asset Management LLC’s Travere Therapeutics Inc Position

Does Exome Asset Management LLC own Travere Therapeutics Inc (TVTX)? Not currently — the last reported position was 89.1K shares worth $3M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q4 2025
Shares
89.1K
% of Portfolio
+1.63%
Quarters Held
7
position exited

Position History TVTX

Reported value by quarter
Q4 ’23: $755,043Q4 ’23Q1 ’24: $3MQ1 ’24Q2 ’24: $4MQ2 ’24Q1 ’25: $2MQ1 ’25Q2 ’25: $2MQ2 ’25Q3 ’25: $4MQ3 ’25Q4 ’25: $3MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202589.1K$3M+1.63%
Q3 2025156.9K$4M+2.27%
Q2 2025153.3K$2M+1.69%
Q1 2025118.0K$2M+1.88%
Q2 2024443.4K$4M+3.17%
Q1 2024362.5K$3M+2.39%
Q4 202384.0K$755,043+0.75%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Exome Asset Management LLC’s full portfolio or all institutional holders of TVTX.